Tonix Pharmaceuticals Holding Corp. (TNXP) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
26 MAIN STREET, SUITE 101 CHATHAM, NJ 07928 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2025 MRQ | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 98,776 | 24,948 | 120,229 | 178,660 | 77,068 | 11,249 | |||
| Cash and cash equivalent | 98,776 | 24,948 | 120,229 | 178,660 | 77,068 | 11,249 | |||
| Receivables | 3,683 | ||||||||
| Inventory, net of allowances, customer advances and progress billings | 8,408 | 13,639 | |||||||
| Inventory | 8,408 | 13,639 | |||||||
| Prepaid expense | 1,392 | 651 | 1,275 | 1,482 | 1,634 | ||||
| Contract with customer, asset, after allowance for credit loss | 881 | 4,590 | |||||||
| Government assistance, asset | 200 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Other undisclosed current assets | 5,662 | 3,940 | 9,273 | 8,907 | 9,287 | 2,699 | |||
| Total current assets: | 119,002 | 47,768 | 130,777 | 189,049 | 87,989 | 13,948 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 565 | 824 | 715 | 914 | 1,258 | 356 | |||
| Property, plant and equipment | 42,252 | 94,028 | 93,814 | 50,558 | 8,571 | 34 | |||
| Intangible assets, net (including goodwill) | 120 | 10,708 | 120 | 120 | 120 | ||||
| Goodwill | 965 | ||||||||
| Intangible assets, net (excluding goodwill) | 120 | 9,743 | 120 | 120 | 120 | ||||
| Restricted cash and investments | 240 | 240 | 100 | ||||||
| Other noncurrent assets | 951 | 1,129 | 384 | ||||||
| Other undisclosed noncurrent assets | 19 | 5 | |||||||
| Total noncurrent assets: | 43,888 | 106,689 | 94,913 | 51,851 | 10,194 | 610 | |||
| TOTAL ASSETS: | 162,890 | 154,457 | 225,690 | 240,900 | 98,183 | 14,558 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 4,546 | 3,782 | 8,068 | 13,282 | 4,598 | 3,070 | |||
| Accounts payable | 4,546 | 3,782 | 8,068 | 13,282 | 4,598 | 3,070 | |||
| Deferred revenue | 1,816 | 2,980 | |||||||
| Debt | 2,820 | 2,350 | 352 | ||||||
| Customer refund liability | 3,658 | 743 | |||||||
| Other undisclosed current liabilities | 5,467 | 9,029 | 10,112 | 8,434 | 5,221 | 1,713 | |||
| Total current liabilities: | 18,307 | 18,884 | 18,180 | 21,716 | 9,819 | 5,135 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 4,667 | 6,561 | 467 | 716 | 6 | ||||
| Long-term debt, excluding current maturities | 4,667 | 6,561 | |||||||
| Liabilities, other than long-term debt | 358 | 23,132 | 328 | ||||||
| Operating lease, liability | 358 | 632 | 328 | 467 | 716 | 6 | |||
| Derivative instruments and hedges, liabilities | 22,500 | ||||||||
| Other undisclosed noncurrent liabilities | 355 | (467) | (716) | ||||||
| Total noncurrent liabilities: | 5,025 | 30,048 | 328 | 467 | 716 | 6 | |||
| Total liabilities: | 23,332 | 48,932 | 18,508 | 22,183 | 10,535 | 5,141 | |||
| Equity | |||||||||
| Equity, attributable to parent | 139,558 | 105,525 | 207,182 | 218,717 | 87,648 | 9,417 | |||
| Common stock | 4 | 59 | 76 | 496 | 206 | 9 | |||
| Additional paid in capital | 870,503 | 706,356 | 677,311 | 578,133 | 355,037 | 226,524 | |||
| Accumulated other comprehensive loss | (255) | (232) | (167) | (92) | (62) | (46) | |||
| Accumulated deficit | (730,694) | (600,658) | (470,038) | (359,820) | (267,533) | (217,070) | |||
| Total equity: | 139,558 | 105,525 | 207,182 | 218,717 | 87,648 | 9,417 | |||
| TOTAL LIABILITIES AND EQUITY: | 162,890 | 154,457 | 225,690 | 240,900 | 98,183 | 14,558 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 10,094 | 7,768 | ||||||
| Cost of revenue | (7,765) | (4,741) | ||||||
| Cost of product and service sold | (1,490) | |||||||
| Gross profit: | 2,329 | 3,027 | ||||||
| Operating expenses | (139,030) | (121,407) | (112,091) | (92,312) | (50,511) | (28,828) | ||
| Operating loss: | (136,701) | (118,380) | (112,091) | (92,312) | (50,511) | (28,828) | ||
| Nonoperating income | 6,665 | 1,722 | 1,873 | 25 | 48 | 210 | ||
| Investment income, nonoperating | 6,150 | 1,722 | 1,873 | 25 | 48 | 210 | ||
| Government assistance, nonoperating income, increase (decrease) | 2,594 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Other nonoperating expense | (2,079) | |||||||
| Interest and debt expense | ||||||||
| Loss from continuing operations: | (130,036) | (116,658) | (110,218) | (92,287) | (50,463) | (28,618) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (92,287) | (50,463) | (28,618) | |
| Net loss: | (130,036) | (116,658) | (110,218) | (92,287) | (50,463) | (28,618) | ||
| Other undisclosed net loss attributable to parent | ||||||||
| Net loss attributable to parent: | (130,036) | (116,658) | (110,218) | (92,287) | (50,463) | (28,618) | ||
| Preferred stock dividends and other adjustments | (6,659) | (1,260) | (2,474) | |||||
| Other undisclosed net loss available to common stockholders, basic | (451) | |||||||
| Net loss available to common stockholders, diluted: | (130,036) | (116,658) | (116,877) | (92,287) | (52,174) | (31,092) | ||
Comprehensive Income ($ in thousands)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (130,036) | (116,658) | (110,218) | (92,287) | (50,463) | (28,618) | ||
| Other comprehensive income | 16 | 5 | ||||||
| Comprehensive loss: | (130,036) | (116,658) | (110,218) | (92,287) | (50,447) | (28,613) | ||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (23) | (65) | (75) | (30) | (32) | (10) | ||
| Comprehensive loss, net of tax, attributable to parent: | (130,059) | (116,723) | (110,293) | (92,317) | (50,479) | (28,623) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.